How to reduce drug prices: One view
Oct 24, 2015
How to reduce drug prices: One view The Opinion of the USA Today Editorial… Read More
© 2025 CSRXP- All Rights Reserved
News & Highlights
AJMC: Rising Drug Costs, Medicare Part D, and Defining Value
Oct 21, 2015
The current pipeline of drugs in the US is unprecedented, said Steve Miller, MD, senior vice president and chief medical officer for Express Scripts. Like Rother, he expressed worries over the current 13% increase in drug prices and the fact that prices are expected to continue to go up. Read More
The Wall Street Journal: Marco Rubio Latest to Speak Out on Prescription Drug Prices
Oct 20, 2015
U.S. Senator Marco Rubio (R-Fla.) became the latest presidential candidate to speak out on prescription drug prices, saying that some pharmaceutical companies are engaging in “pure profiteering” and that high prices threaten to “bankrupt our system.” Read More
Bloomberg: Drug Politics Go Republican as Rubio Criticizes Industry
Oct 20, 2015
“It’s a new issue that’s emerged over the last few years but it’s a significant one, because it threatens to bankrupt our system,” Rubio said after being asked about drug prices by an audience member. “It’s a complex issue but it’s one we have to confront.” Read More
POLITICO: Rubio blasts drug company ‘profiteering’
Oct 16, 2015
Republican presidential contender Marco Rubio blasted pharmaceutical company “profiteering” on high-cost prescription drugs during a campaign stop this week – a sign that drug prices are becoming a lightning rod for both parties in the election. Read More
Group targeting drug costs enters early primary states
Oct 2, 2015
POLITICO Group targeting drug costs enters early primary states By Brett… Read More
Sanders: Drug costs are out of control
Oct 1, 2015
Across the country, Americans are finding the prices of the prescription drugs… Read More
Drug firms need to explain the prices
Sep 29, 2015
Drug makers do not really want to explain how medicines are priced and, as a result, they have adopted an air of secrecy in which one cowboy can create havoc for an entire industry. Read More
NYT: A Huge Overnight Increase in a Drug’s Price Raises Protests
Sep 20, 2015
Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection. Read More
The Price for Lowering Cholesterol
Sep 9, 2015
The hepatitis C drugs, which cured a vast majority of patients in clinical trials, are essentially a one-time cost. The cholesterol drugs, by contrast, will be taken for a lifetime. At these rates, the lifetime costs could be staggering. Read More
New Cholesterol Drugs Are Vastly Overpriced, Analysis Says
Sep 9, 2015
Two powerful new drugs that can sharply lower cholesterol are vastly overpriced based on the value they provide, according to a new analysis by an independent organization that evaluates pharmaceutical costs. Read More
New effective medicines are of no use if they are unaffordable
Sep 9, 2015
The pharmaceutical industry have, in recent years, focused on development of so-called specialty drugs and have priced them aggressively. These prices, such as the US$1,000 per pill price for the hepatitis C drug sofosbuvir, are alarming for patients, employers, insurers, and governments. Read More